Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nathan Burton

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Progress in Molecular Biology and Translational Science|September 22, 2023
Host-phage interactions and modeling for therapyJoshua Williams, Nathan Burton, Gurneet Dhanoa, et al.
Transplantation and Cellular Therapy|September 19, 2021
Severity of Acute Graft-versus-Host Disease and Associated Healthcare Resource Utilization, Cost, and OutcomesNosha Farhadfar, Helen L Leather, Shu Wang, et al.
Scientific Reports|May 8, 2023
Antibacterial activity of vB_AbaM_PhT2 phage hydrophobic amino acid fusion endolysin, combined with colistin against Acinetobacter baumanniiSutthirat Sitthisak, Suphattra Manrueang, Supat Khongfak, et al.
Clinical Trials (London, England)|July 5, 2021
Using simulated infectious disease outbreaks to inform site selection and sample size for individually randomized vaccine trials during an ongoing epidemicZachary J Madewell, Ana Pastore Y Piontti, Qian Zhang, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Progress in Molecular Biology and Translational Science|September 22, 2023
Host-phage interactions and modeling for therapyJoshua Williams, Nathan Burton, Gurneet Dhanoa, et al.
Transplantation and Cellular Therapy|September 19, 2021
Severity of Acute Graft-versus-Host Disease and Associated Healthcare Resource Utilization, Cost, and OutcomesNosha Farhadfar, Helen L Leather, Shu Wang, et al.
Scientific Reports|May 8, 2023
Antibacterial activity of vB_AbaM_PhT2 phage hydrophobic amino acid fusion endolysin, combined with colistin against Acinetobacter baumanniiSutthirat Sitthisak, Suphattra Manrueang, Supat Khongfak, et al.
Clinical Trials (London, England)|July 5, 2021
Using simulated infectious disease outbreaks to inform site selection and sample size for individually randomized vaccine trials during an ongoing epidemicZachary J Madewell, Ana Pastore Y Piontti, Qian Zhang, et al.
Pageof 1